Elena Garralda’s ESMO On Target column: Good night for Good? Preventing sleeping cancer cells from awakening
Following her debut column as author of [...]
A hand-pick of latest VHIO research highlights aimed at the more precise diagnosis of familial breast and ovarian cancer
Barcelona, August 02, 2021. The BRCA1 and BRCA2 [...]
The COVID-19 era & the heightened risk of burnout in our young oncologists
Promoted by the +MIR Spanish Society of [...]
Probody: the promise of ‘kinder’ antibody-based immunotherapy
Barcelona, July 27, 2021. Recently published ahead of [...]
Expert panel discussion: current opportunities, challenges, and future directions of genomic testing for prostate cancer
During this month’s 36th Annual Virtual Congress [...]
Seeking out prognostic & predictive biomarkers: VHIO’s Elena Élez on cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer
Recently headlining at the European Society for [...]
The immune microenvironment as a driver of disease progression in chronic lymphocytic leukemia
Research led by VHIO investigators represents a [...]
Cancer Core Europe’s DART website now live and ready for visitors
Officially announced earlier this year, the EU-funded [...]
Closing in on Myc inhibition: a marathon sprint finish?
Barcelona, June 23, 2021. Published today in the Journal [...]
PEGASUS: liquid biopsy to personalize treatment decision-making post-surgery
Announced today, the PEGASUS study will assess [...]